What this means
Researchers plan to test health measurements taken at the start and over a lifetime. They want to see whether these measures predict death, serious disease, or disability. The trial has not reported results, so it cannot yet show what the measures predict.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18 and over
- Where
- 1 site, including Colorado
The science
- Registered title
- 100-Year Human Aging Study
- Trial ID
- NCT07563777 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Aging, Aging Well, All-Cause Mortality, Mortality, Metabolic Syndrome, Cardiovascular Diseases, Cognitive Dysfunction, Musculoskeletal Diseases, Neoplasms, Frailty, Activities of Daily Living, Health-Related Quality of Life, Disability Physical, Neuro-Degenerative Disease, Dementia
- What is tested
- Comprehensive Multi-System Clinical Screening
- Sponsor
- Longevity Metrics, Inc.
- Ages
- 18 Years to no maximum
- Dates
- First posted May 4, 2026 · updated Sep 8, 2026
Registry summary
The 100-Year Human Aging Study is a prospective, pragmatic, observational trial enrolling participants across fixed clinical sites, mobile clinical sites, and an online participation pathway (current and future) to undergo comprehensive multi-system health screening and longitudinal follow-up until death. Participants are followed to determine whether measurements taken at enrollment and repeated across the lifespan - individually and in combination - predict all-cause mortality, cause-specific mortality, incident serious disease, and functional disability. The study is designed to generate the surrogate endpoint validation data that longevity medicine currently lacks.
Sites (1)
- Longevity Metrics, Boulder, Colorado, United States